Pharmacokinetics of isoniazid in children with tuberculosis—A comparative study at two doses
- 7 January 2020
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (3) , 660-665
Abstract
Aim: To compare the pharmacokinetics of isoniazid (INH) at doses 5 and 10 mg/kg/day.Methods: INH concentrations were estimated by high‐performance liquid chromatography in 24 Indian children aged 1 to 15 years on antituberculosis therapy. Blood samples were collected at 0, 2, 4, 6, 8 hours after administration of INH. Patients were randomly given INH at 5 or 10 mg/kg/day and maximum concentrations (Cmax) and area under the curve (AUC(0‐8)) were determined in each group. The 2‐hour concentration of INH was used as Cmax for this study.Results: Mean (standard deviation) Cmax was reached in 2 hours and was 2.68 ± 1.19 µg/mL in 5 mg/kg/day group and 8.86 ± 3.94 µg/mL in 10 mg/kg/day group (P < .05). The normal therapeutic range at 2‐hour concentrations for INH in adults achieving good clinical response is between 3 and 5 µg/mL. Among 5 mg/kg/day, only 4 (33%) patients had INH concentrations within the 2‐hour concentrations therapeutic range whereas in 10 mg/kg/day group, 11 (91%) patients achieved Cmax higher than the 2‐hour concentrations therapeutic range and 1 (9%) patient had Cmax within the 2‐hour concentrations therapeutic range. The mean AUC(0‐8) in 5 mg/kg/day group was 10.04 ± 6.12 and 35.93 ± 25.37 µg·h/mL in 10 mg/kg/day group (P = .0001).Conclusion: Children on daily INH 10 mg/kg/day have higher AUC and Cmax than the required therapeutic range whereas over 65% of children with daily 5 mg/kg/day INH therapy failed to achieve the optimal therapeutic range.Keywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian childrenBMC Infectious Diseases, 2015
- Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian childrenIndian Pediatrics, 2015
- Impact of HIV on clinical presentation and outcomes of tuberculosis treatment at primary care level [Short communication]The International Journal of Tuberculosis and Lung Disease, 2013
- Simple and rapid liquid chromatography method for simultaneous determination of isoniazid and pyrazinamide in plasmaSAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, 2012
- Isoniazid Pharmacokinetics, Pharmacodynamics, and Dosing in South African InfantsTherapeutic Drug Monitoring, 2012
- Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization RecommendationsAntimicrobial Agents and Chemotherapy, 2011
- Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing GuidelinesClinical Infectious Diseases, 2009
- Low Levels of Pyrazinamide and Ethambutol in Children with Tuberculosis and Impact of Age, Nutritional Status, and Human Immunodeficiency Virus InfectionAntimicrobial Agents and Chemotherapy, 2006
- Isoniazid pharmacokinetics in children treated for respiratory tuberculosisArchives of Disease in Childhood, 2005
- Isoniazid and its Hydrazine Metabolite in Patients with TuberculosisClinical Drug Investigation, 1999